Skip to main content

Clinical Trials

Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.

This currently recruiting study will support FDA submission of Tandem’s Control-IQ hybrid closed loop for children six years of age or older
A trial is enrolling over 3,000 individuals living with type 2 diabetes and chronic kidney disease
A trial in Boston is enrolling 168 individuals ages 65 years and older with type 1 diabetes to investigate the combination of CGM and education to reduce hypoglycemia
A currently recruiting study to find out how blood sugar changes during exercise in people with type 1 diabetes
A currently-recruiting study will provide access to some of the world’s leading diabetes psychologists, support groups, and strategies to reduce distress and improve...
A new study provides CGM training, insulin dosing support, and mental health services through a fully virtual model to see if virtual specialty care can effectively help...
The REAL-T clinical trial is currently recruiting – it will provide lifestyle-based telehealth support to young adults with type 1 diabetes to see if it helps improve...
The RADIANT study aims to define unusual forms of diabetes, to help diagnose and treat these conditions. RADIANT is recruiting people who have been diagnosed with...
Are you interested in trying oral insulin? If you are an adult with type 2 diabetes, take part in a 26-week clinical trial that’s studying how well an insulin pill can...
Calling all adults with prediabetes or type 2 diabetes: The T2Help study is recruiting 280 participants for a 16-week virtual clinical trial to collect continuous...
This clinical trial is currently recruiting. Families will participate in weekly sessions that focus on topics related to diabetes distress and parent-teen communication...
Do you have type 2 diabetes and heart disease? In this clinical trial called SURPASS-CVOT, researchers are studying the use of tirzepatide, a new glucose lowering...
The FDA recently approved BYDUREON BCise (an extended-release version of the GLP-1 drug, exenatide) for teens with type 2 diabetes. Recently published data shows...
Help researchers evaluate and improve gestational diabetes screening and diagnosis – share this clinical study with anyone you know who is newly pregnant to see if they...
A remote six-month clinical trial is recruiting 150 children between the ages of two to five whose families are interested in trying automated insulin delivery. The...

Pages